Last reviewed · How we verify
NCT07104513: RLRL
Efficacy and Influencing Factors of Repeated Low-level Red-light in Myopia
trial testing Red Light in Myopia in 3,000 participants. Participants enrolled and being followed up; not accepting new ones.
28 July 2028
Quick facts
| Lead sponsor | Ruihua Wei |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 3,000 |
| Start date | 28 September 2020 |
| Primary completion | 28 July 2028 |
| Estimated completion | 28 July 2030 |
| Sites | 2 locations across China |
Drugs / interventions tested
- Red Light
Conditions studied
- Myopia — all drugs for Myopia →
Sponsor
Ruihua Wei — full company profile →
Who can join
Adults 5 to 16, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the long-term efficacy of repeated low-level red-light (RLRL) therapy in the prevention and control of myopia in children, and to analyze the key factors influencing its efficacy (such as individual differences and compliance), with the aim of providing evidence-based support for the optimization of clinical myopia prevention and control strategies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07104513
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Red Light
Trials testing the same drug.
- NCT06418958 — Temperature Rise Caused by Short or Long-wavelengths · NA · recruiting
- NCT06855992 — Transcutaneous Laser Therapy in Chronic Kidney Disease · NA · not yet recruiting
- NCT05712772 — Neuro-affective Response to Light in Depressed Adolescents and Young Adults · NA · recruiting
Other recruiting trials for Myopia
Currently open trials in the same condition.
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
Other Ruihua Wei trials
Trials by the same sponsor.
- NCT07186088 — Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies · NA · not yet recruiting
- NCT07160036 — Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Ther · NA · recruiting
- NCT06523504 — Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07104513 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ruihua Wei
- Last refreshed: 8 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07104513.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing